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Abstract
Background: User mobility is an important aspect of the development of clinical information systems for health care professionals.
Mobile phones and tablet computers have obtained widespread use by health care professionals, offering an opportunity for
supporting the access to patient information through specialized applications (apps) while supporting the mobility of the users.
The use of apps for mobile phones and tablet computers may support workflow of complex tasks, for example, molecular-based
diagnostic tests in clinical microbiology. Multiplex Blood Culture Test (MuxBCT) is a molecular-based diagnostic test used for
rapid identification of pathogens in positive blood cultures. To facilitate the workflow of the MuxBCT, a specialized tablet
computer app was developed as an accessory to the diagnostic test. The app aims to reduce the complexity of the test by step-by-step
guidance of microscopy and to assist users in reaching an exact bacterial or fungal diagnosis based on blood specimen observations
and controls. Additionally, the app allows for entry of test results, and communication thereof to the laboratory information system
(LIS).
Objective: The objective of the study was to describe the design considerations of the MuxBCT app and the results of a
preliminary usability evaluation.
Methods: The MuxBCT tablet app was developed and set up for use in a clinical microbiology laboratory. A near-live simulation
study was conducted in the clinical microbiology laboratory to evaluate the usability of the MuxBCT app. The study was designed
to achieve a high degree of realism as participants carried out a scenario representing the context of use for the MuxBCT app.
As the MuxBCT was under development, the scenario involved the use of molecular blood culture tests similar to the MuxBCT
for identification of microorganisms from positive blood culture samples. The study participants were observed, and their
interactions with the app were recorded. After the study, the participants were debriefed to clarify observations.
Results: Four medical laboratory technicians, for example, representative of end users of the app, participated in the clinical
simulation study. Using the MuxBCT app, the study participants successfully identified and reported all microorganisms from
the positive blood cultures examined. Three of the four participants reported that they found the app useful, while one study
participant reported that she would prefer to make notes on paper and later enter them into the LIS.
Conclusions: The preliminary usability evaluation results indicate that use of the MuxBCT tablet app can facilitate the workflow
of the MuxBCT diagnostic test.
(JMIR mHealth uHealth 2016;4(1):e20)   doi:10.2196/mhealth.5041
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Introduction
Health Care Workers and Mobile Technology
Support of user mobility is an important aspect to consider when
developing clinical information systems (CIS) [1-3]. Physicians
and nurses continuously move between offices, wards, patients,
and workstations while conducting their work. Other employees
such as laboratory workers are also mobile in their work, as
they move between labs, specialized equipment, and offices to
acquire and report laboratory results [4]. With the ongoing trend
of increased digitization of information in health care and thus
a move away from paper documentation, this sets a requirement
for clinical staff being able to access CIS while away from
workstations.
In recent years, mobile devices in the form of mobile phones
and tablet computers have become almost ubiquitous in daily
life and their use has spread to clinical settings [5-7]. The mobile
devices are generally lightweight, intuitive to use, and contain
powerful data processing abilities. Thus, they offer a potential
solution for providing the necessary access to CIS, while
supporting the mobility requirements of health care
professionals. While mobile phones and tablet computers are
seeing more widespread use by health care professionals in
clinical settings, there is still a need for more research to
discover and document the benefits and potential difficulties
these mobile devices may bring to particular applications (app)
[7,8].
Mobile phones and tablet computers offer an interesting option
for providing workflow assistance and guidance of complex
tasks. For example, in clinical laboratories the development of
specialized apps may facilitate the workflow of preparing,
interpreting, and reporting results of diagnostic tests. In clinical
microbiology, many new diagnostic tests have been developed
in recent years that allow for rapid identification of
microorganisms that cause bloodstream infections [9]. Many
of these tests are based on molecular biology techniques and
have the potential for providing more specific results in a shorter
time than current tests. However, the molecular tests are often
more complex to use compared to the conventional techniques
and therefore may require more skill from the operators [10].
Multiplex Blood Culture Test
Multiplex Blood Culture Test (MuxBCT) (AdvanDx, Woburn,
MA, USA) is a new blood culture diagnostic test under
development based on the molecular technique fluorescence in
situ hybridization (FISH). The MuxBCT uses
fluorescence-labeled, peptide nucleic acid (PNA) probes that
bind to specific DNA targets in microorganisms, which can
then be detected by fluorescence microscopy. Like other
molecular diagnostic tests, the MuxBCT involves more
complexity than conventional methods used for blood culture
diagnostics in clinical microbiology. To reduce the time required
for data capture, test interpretation, and results reporting, a
MuxBCT tablet computer app was developed as a research
project. The aim of the app is to reduce the complexity of the
diagnostic test by guiding the user, for example, a medical
laboratory technician (MLT), stepwise through the diagnostic
test and the interpretation process of the MuxBCT diagnostic
test. Additionally, the app will allow users to report results
directly to the Laboratory Information System (LIS).
In this study, we describe the system design and development
considerations for the MuxBCT tablet app, and we report the
results of a preliminary usability evaluation of the MuxBCT
app.
The Multiplex Blood Culture Test App
App Description
The MuxBCT app has been developed as a research project and
functions as an accessory tool to facilitate the use of the
MuxBCT diagnostic test. The app was developed based on
requirements set through observations of the workflow during
blood culture analysis in a clinical microbiological laboratory
[4]. End users have been involved in the development life cycle
of the MuxBCT app, for example, by identifying flaws in a
prototype of the app through a participatory heuristic evaluation
[11]. The app is integrated with the LIS in use at the Department
of Clinical Microbiology (DCM) at Aalborg University Hospital,
Denmark. The LIS integration of the app is important for clinical
use, as a lack of an integration would require reentry of test
results and likely lead to an inefficient and more error-prone
workflow [12]. The MuxBCT app is developed as a native app
for the Android operating system and has been designed to
support 10.1-inch tablet computers.
When using the app, users must initially complete a sample
setup (Figure 1 shows this), where the sample identification
number is entered into the app. The sample identification
number can optionally be entered via a barcode reader. The
entered sample identification number is used to retrieve relevant
clinical information about the patient and that sample from the
LIS, which is then displayed to the user. The user selects one
or more positive blood cultures for analysis. The Kit ID (lot
information) for each MuxBCT diagnostic test used must be
entered for each selected blood culture. The lot information is
stored for quality control purposes.
The MuxBCT diagnostic test is divided into 10 different analysis
areas (wells). In most cases, a classification well followed by
three identification wells will need to be examined. The user
will start fluorescence microscopy with a classification well
and will be prompted to enter the findings into the app through
the use of multiple choice questions. The app has an algorithm
that guides users to analyze only relevant wells based on
observations entered for the classification well. During analysis
of the selected identification wells (Figure 2 shows this), the
user will again enter observations via multiple choice questions.
In the user interface, users can choose to display reference
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images of the same type of fluorescent microorganism to assist
them in analyzing their observations.
When the user has completed the test analysis, a result summary
of any microorganism findings, for example, a bacterium finding
and a yeast finding, will be displayed to the user. Once the user
has submitted the analysis result, it becomes available for all
relevant staff through the LIS. The user also has an option to
enter notes along with the result, which will either be visible
for all clinical staff or only staff in the clinical microbiology
laboratory. Until the result is submitted to the LIS, users can
go back in the app and revise any entered data.
The app offers a training mode where fictitious data are
generated and displayed to the user. In the training mode, no
data are communicated between the LIS and the tablet app. The
training mode allows users to become familiar with the app
before they use it to facilitate the analysis of positive blood
culture samples.
Figure 1. Sample screenshot of the Multiplex Blood Culture Test (MuxBCT) app showing the initial sample setup where a sample ID is entered into
the system, data are retrieved from the Laboratory Information System (LIS), and displayed in the app. The patient information displayed in the image
is fictitious.
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Figure 2. Sample screenshot of the Multiplex Blood Culture Test (MuxBCT) app showing data entry of test results acquired through fluorescence
microscopy of the MuxBCT diagnostic test. The patient information displayed in the image is fictitious.
System Architecture
The MuxBCT system consists not only of a tablet computer
with the MuxBCT app, but also of a server with a MuxBCT
server app (Figure 3 shows this). The MuxBCT server
communicates with the LIS of the clinical microbiology
laboratory. Additionally, the tablet app supports the use of a
Bluetooth barcode scanner as an accessory for the MuxBCT
app to reduce the potential for data entry errors [13]. Once the
scanner is connected, it allows for data entry by scanning sample
identification barcodes. The MLTs interact directly with the
MuxBCT tablet app during analysis of a MuxBCT diagnostic
test.
The app exchanges data with a MuxBCT server, which is
integrated with the LIS. The server processes any results
received by the tablet app, so that the data can be exchanged
with the LIS. The server app communicates with the LIS to
receive patient information relevant to the sample being
analyzed and to store results of the MuxBCT diagnostic test in
the LIS. Once data have been transmitted to the LIS, they
become available for clinical microbiologists, who can access
it through the LIS. The clinical microbiologists can then
communicate the results to a patient’s treating physician to
optimize the patient’s treatment. When the DCM has approved
the results in the LIS, the results become available from the
electronic health records system through LIS integration.
A database is associated with the MuxBCT server, which is
used to store test results. This allows data to be reviewed for
quality assurance purposes. Additionally, user interactions with
the system are logged in the MuxBCT database.
Figure 3. Overview of the Multiplex Blood Culture Test (MuxBCT) system design. The medical laboratory technician (MLT) will use the MuxBCT
app for facilitation of the MuxBCT diagnostic test. The MLT can use a wireless barcode scanner to enter barcodes into the tablet app. Clinical
microbiologists can access the MuxBCT results through the LIS. The HTTPS protocol is used to ensure encrypted communication of data. The arrowheads
indicate direction of data flow. Dashed lines in the figure indicate wireless connections.
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System Security
Because of an inherent risk of tablet computers more easily
being misplaced or stolen than regular workstation computers,
several security design considerations have been built into the
MuxBCT app, which aims to keep patient data secure and
private (Figure 4 shows this). The security design considerations
are divided into three categories: user security, device security,
and data security.
The user security design considerations consist of user
authentication and of logging user interactions. To gain access
to the functionality of the MuxBCT app, a user must provide a
username and password, which must then be successfully
authenticated. Additionally, any user interaction that provides
access to patient information will be saved as a log entry in the
MuxBCT server’s database. This enables an audit functionality,
where any potential misuse of the system can be tracked, and
users can be held accountable for their actions.
The device security is based upon not storing any data locally
on the tablet computer and automatically logging out inactive
users. To prevent potential patient data leaks, the app is designed
to store data only temporarily in the memory of the tablet
computer while the MuxBCT app is being used. Once a user
completes a task with the app, any information related to that
task is cleared from the tablet computer. If any users are inactive
for more than a predefined period, for example, 20 minutes, the
system will automatically log the user out of the system. The
user will then have to authenticate again if she wishes to resume
using the MuxBCT app. The system administrator can adjust
the inactivity period that must pass before a user is logged out
of the system.
Letting the tablet app exchange data with the MuxBCT server
only through the hospital’s secure Wi-Fi network ensures data
security. Additionally, all data communication is protected with
encryption that relies on the HTTPS protocol (Figure 3). By
encrypting the Bluetooth connection, data entered using an
accessory Bluetooth barcode scanner are protected.
Figure 4. Overview of the security design considerations that in unison protect the patient information of the Multiplex Blood Culture Test (MuxBCT)
application (app). It is a requisite that the security considerations are implemented before the deployment of the MuxBCT app. Wi-Fi is the local wireless
network.
Methods
Study Design
To gain insights about the use of the MuxBCT app, a
preliminary usability evaluation was conducted at the DCM at
Aalborg University Hospital. This allowed the app to be tested
in its normal context of use. The evaluation was structured as
a clinical simulation study and aimed for a high degree of
realism. The study took place within normal working hours at
the DCM, which meant that normal minor background
disturbances occurred, which further aided in making the study
a near-live simulation for the participants. A scenario of use
with a focus on realistic tasks was developed in cooperation
with staff at the DCM, where the MuxBCT app was used to
support result interpretation and data entry of FISH-based blood
culture diagnostic tests. A pilot study was conducted with one
MLT to validate the study design before the main study took
place.
The study aimed to recruit 4-5 participants, which is commonly
used as a cost-efficient approach for finding usability problems
through usability evaluation methods [14]. An informational
flyer about the study was presented to the MLTs of the DCM.
For inclusion in the study, participants were required to have
prior experience with blood culture analysis. Potential
participants were excluded if they had any prior experience with
MuxBCT or the MuxBCT app prototype. A senior staff member
of the DCM handled selection of participants for the study, with
a goal of achieving a mixed level of seniority among the
participants. The participants were compensated for their time.
At the onset of each study session, the participants were
introduced to the concept of the MuxBCT diagnostic test and
the accessory tablet app. The first author acted as test leader
during the study and provided the users with instruction and
training. The study participants then participated individually
in a MuxBCT app training session lasting roughly 10 minutes.
The training session followed a structured approach so each
participant had the same introduction to the app. If the study
participant was not familiar with tablet computers and the
Android operating system, they were given a brief introduction
to this. Once the participant was comfortable with the tablet, a
scenario of use of the MuxBCT app was described for the
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participant. Each participant carried out 5 predefined tasks using
the MuxBCT app. The 5 tasks were divided into 24 steps, for
which they received instructions to complete one at a time. If
the participant was stuck on a step, they were allowed to ask
questions and to receive help from the test leader.
During the study, the participants were not offered any
assistance in the interpretation of diagnostic test results or in
the use of the app. The participants were asked to think-aloud
during the study. After the study, the participants were debriefed
in a short interview that followed a semistructured approach,
which was based on the observations made by the test leader
during the study.
The test leader acted as an observer during the study and took
notes of the participants’ interactions with the tablet app and
the diagnostic tests. Furthermore, all interactions with the tablet
app were recorded as a video file with the Android app
Recordable, where user interactions with the app, for example,
touch gestures, were saved as an overlay on the video. Audio
was recorded using a dictation machine and by the built-in
microphone of the tablet computer. The video and audio files
were transferred to a computer and synchronized, allowing for
analysis of the study results.
The debriefing interviews and the audio data from the users’
interaction with the app were analyzed by coding the data
through the process of meaning condensation and categorization
followed by an interpretation of the processed data [15]. An
inductive approach was used in the analysis of video data, which
was supported by the audio data of users thinking aloud during
their interaction with the app. Different types of events were
coded in categories based on their characteristics. Once
structured into themes and categories, the data were summarized,
which allowed for an analysis of the total time spent for
MuxBCT analysis. In addition, the structured data were
interpreted, which allowed for identifying the users’perspectives
about potential difficulties when interacting with the app.
Materials
The MuxBCT diagnostic test was undergoing development at
the time of the study. While the general concepts of the test
were fully designed, it was not ready for use in a clinical
microbiology laboratory. Therefore, the MuxBCT was
unavailable at the time of the study. Instead, MuxBCT was
simulated by using the QuickFISH Enterococcus and QuickFISH
Candida (AdvanDx, Woburn, MA, USA) tests. The QuickFISH
tests are predecessors to the MuxBCT and require the same
fluorescence microscopy analysis to interpret test results, but
each QuickFISH test identifies fewer microorganisms. By using
the QuickFISH tests, two out of ten analysis wells of the
MuxBCT were simulated. The use of the two QuickFISH tests
necessitated that the study participants changed the microscopy
slide once during the analysis phase. As part of the training
session, it was explained to the participants that the QuickFISH
tests were used to simulate the MuxBCT.
A senior MLT who had been involved in the MuxBCT app
development process assisted in the study by helping with the
preparation of the QuickFISH tests. Additionally, the senior
MLT inoculated samples drawn aseptically from blood culture
bottles negative at termination of incubation (BacT/Alert,
bioMérieux, Marcy l’Etoil, France) with the bacteria,
Enterococcus faecalis or Enterococcus faecium, and the yeasts,
Candida albicans or Candida glabrata, so that each sample
grew two of these microorganisms. Each study participant was
assigned a random blood culture sample to analyze using the
QuickFISH test kits. The study participants were kept blinded
to the microorganisms in their assigned blood culture sample.
For the study, the MuxBCT app was installed on a Samsung
Tab Pro 10.1-inch tablet computer (Samsung Electronics, Seoul,
Korea) running Android 4.4.2. All text in the app was in Danish,
the first language of the study participants. The tablet was
connected to a CHS 7DiRx 1D Bluetooth barcode scanner
(Socket Mobile, Newark, CA, USA) and the hospital’s secure
Wi-Fi network. Access to the secure Wi-Fi network was
approved by the hospital’s Information Technology Department
before the study took place.
In preparation for the study, the MuxBCT app was connected
to the MuxBCT server. However, because the study was a
simulation, the MuxBCT server was not connected to the LIS
during the study, but instead returned realistic, fictitious patient
data to the tablet app. All MuxBCT analysis results were sent
to the server and saved in the associated database for later
validation.
Results
Study Participants
There were four MLTs that participated in the clinical simulation
study, which was conducted in one day at the DCM. All study
participants were female. The mean age of the study participants
was 37 years, and the mean experience in blood culture
diagnostics was 7 years (range 3-14 years). There were three
participants that described their skill level with fluorescence
microscopy as practiced, while one described her skill level as
novice. All participants described themselves as experienced
in the use of mobile phones and tablet computers based on
personal use outside the clinical microbiology department. The
study spanned across several rooms in the clinical microbiology
department. Preparation of the QuickFISH molecular tests took
place in one room with specialized equipment primarily for
molecular diagnostics. The interpretation of the tests required
fluorescence microscopy and took place in a dark room that
was located near the first room. Training and debriefing took
place in a larger room in the department, where there was little
activity and few potential disturbances.
Participant Results
All participants correctly identified all microorganisms in the
simulated blood culture samples. The participants correctly
entered their findings into the MuxBCT app and submitted them
to the MuxBCT server. The analysis results were retrieved from
the database of the MuxBCT server to verify that they had been
transmitted successfully. It was confirmed that all results were
stored correctly in the database. On average, the analysis of the
blood culture sample and data entry of the results into the
MuxBCT app took 10.2 min (range 6.5-16.0 min).
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All results were entered correctly on the first attempt. However,
when two participants attempted to mark their findings, they
initially changed the reference image being displayed instead;
this was the result of clicking on the microscope icon associated
with each possible finding instead of marking the checkboxes
corresponding to their findings (Figure 4). Both participants
noticed that they had not entered the results and marked their
findings successfully before continuing.
During the debriefing interview, three participants expressed
that they found the system useful. A participant noted that she
would prefer to continue making notes of analysis results on
paper and entering them later into the LIS at a workstation. The
main reasoning behind this was that the text on the tablet
computer was too small to read during data entry (Figure 4).
Another participant also expressed an interest in larger text on
the app. Both of these participants wore glasses, which they
would remove during use of the fluorescence microscope.
It was observed for all participants that they made only minor
use of the reference images displayed during data entry. When
prompted about this during the debriefing, two participants
explained that the reference images were not needed during the
study, as the samples being analyzed by fluorescence
microscopy provided a clear picture. They remarked that the
reference images would be useful in cases where the
fluorescence signal was less clear. A participant noted that the
reference images would likely be most valuable for users with
limited experience in fluorescence microscopy.
All participants used the barcode scanner successfully to enter
sample identification data into the app. A participant initially
had troubles entering the sample identification with the barcode
scanner because the relevant input field had not been selected
before the barcode was scanned (Figure 4). Throughout the
study, the Bluetooth barcode scanner functioned without loss
of connection to the tablet computer. There were three
participants that expressed that the mobility of the tablet in
combination with the barcode scanner was satisfactory; however,
one participant suggested that a slightly smaller tablet computer
could be used.
The majority of the app’s security features were enabled and
used successfully during the study. The user authentication was
not enabled, as study participants logged in with fictitious user
data. Additionally, the user inactivity detection was not enabled
in the app, as the study participants were not involved in normal
job functions during the study, and thus there was no risk of
inactivity for long periods. During the study, there were no
issues with loss of connection to the Wi-Fi network at the DCM.
Discussion
Principal Results
The MuxBCT tablet app was developed as a research project
for the facilitation of the MuxBCT diagnostic test that is
designed for rapid identification of bacterial and fungal
pathogens in positive blood cultures. This study describes the
MuxBCT app and a preliminary usability evaluation of the
MuxBCT tablet app based on a clinical simulation study
conducted at a clinical microbiology laboratory. The MuxBCT
diagnostic test is intended to provide fast and accurate
identification of microorganisms causing bloodstream infections,
allowing the physician to treat with more appropriate
antimicrobials sooner. However, the use of molecular diagnostic
tests such as MuxBCT involves a more complex workflow than
conventionally used methods of analysis [10]. Specialized apps
such as the MuxBCT app may facilitate the workflow of
diagnostic tests in the clinical laboratory, which can lead to a
more accurate and faster result. In the case of treating patients
with severe sepsis, this is critical, as each hour of delay in the
administration of an effective antimicrobial treatment is
associated with a decrease in survival rate [16]. While some
specialized apps may be more suitable for use on existing
workstation PCs, which are commonly distributed throughout
clinical laboratories, this is not a practical solution for the
MuxBCT app, as MuxBCT requires use in a dark room due to
the use of fluorescence microscopy for reading the test results.
As the app is designed to guide users through the interpretation
process in a stepwise manner, the app needs to be accessible
directly from the location where the test is being analyzed. The
results of this study indicate that although there were some
usability issues for the users to interact with the tablet in the
dark room, the app was viewed as a useful adjunct to this kind
of test and that the light from the tablet did not disturb the
analysis process.
All participants in the study managed to correctly identify and
report the microorganisms from the blood culture samples they
examined. The foundation for the use of the app was a short
training session. The participants were able to use the MuxBCT
app for guidance during the examination of the QuickFISH
molecular diagnostic tests. The QuickFISH tests with the same
detection method were used to simulate the MuxBCT, which
was still undergoing development at the time of the study. The
initial classification well could not be simulated by use of
QuickFISH tests in a realistic manner, so, as a compromise, the
participant received instructions of what findings to input for
this well. The classifier is a molecular equivalent to the classical
Gram stain with minor differences in distinction between
bacterial groups. Common use of the MuxBCT would require
analysis of the classifier well followed by analysis of three
identification wells. The analysis of additional identification
wells is only necessary when the results from the classification
well indicate a polymicrobial bloodstream infection.
The participants were able to access the necessary clinical
information they required during the test without having to
access the LIS using a workstation. Additionally, all participants
successfully made use of the barcode scanner during the study.
During the debriefing interviews, three out of four participants
expressed that they found the system useful. A participant
expressed a preference for writing the results on paper, for
example, like the normal workflow during blood culture
analysis, and later entering the results into the LIS. Some
usability issues were noted during the study, but overall the
usability evaluation found that the MuxBCT app was a reliable
tool for facilitating the workflow of the MuxBCT diagnostic
test, as all participants managed to correctly interpret, enter,
and communicate the test results.
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The results of the study have led to some updates of the
MuxBCT app. The main structure of the app has not been
changed; however, several changes have been made to improve
the user interface of the app. For example, the font size has been
increased throughout the app, making text more easily readable,
and the check boxes where users mark their findings of
microorganisms have been increased in size.
Based on the results of the development process and this study,
we believe that the involvement of clinical microbiology staff
in the development and evaluation processes of the MuxBCT
app has led to an improved quality of the app. In general, there
is a growing focus on the need for involvement of medical
professionals throughout the entire app development process
to ensure the quality of the app and to prevent possible patient
harm [17].
The structure of the study was a near-live clinical simulation
that aimed for a high degree of realism. The study was
conducted in a clinical microbiology laboratory using simulated
blood culture samples, molecular diagnostic tests, and
fluorescence microscopy. The combination of these factors
allowed the MLTs in the study to carry out their analysis with
minimal assistance from the test leader. This provided findings
about the usability of the system, which may not have been
discovered if other usability evaluation methods had been
applied. The use of a think-aloud protocol may have detracted
from the realism of the study. However, this did not seem to
cause any issues during the study. Furthermore, the think
aloud-protocol was necessary to gain knowledge of the
fluorescence microscopy observations and to confirm that the
participants entered their observations correctly. The realism
of the study may have been further diminished by a senior MLT
assisting with the preparation of the QuickFISH tests and by
the test leader observing the participants during the study, but
this did not affect the context of use for the MuxBCT tablet app.
Therefore, it is unlikely that it had any large impact on the
results of usability evaluation.
A challenge in selecting a device for the MuxBCT app was to
ensure mobility of the system, while providing enough screen
space for displaying the necessary information clearly and
allowing for easy input of data. The mobility of the system was
tested as the study spanned several rooms in the clinical
microbiology laboratory. Although the app has been designed
for use on a 10.1-inch tablet computer, two of the study
participants noted that they would prefer text size in the app to
be increased. In regards to the mobility of the system, three
study participants noted that they found the mobility of the
system adequate, while one study participant would prefer a
smaller tablet computer. It may be possible to redesign the app
to support a slightly smaller tablet computer, while increasing
the text size. However, this requires a careful redesign of the
graphical user interface.
While the MuxBCT app was not connected to the LIS during
this study, it was connected to the MuxBCT server. This meant
that it was possible to test communication of test results and to
validate that they were transferred correctly. To simulate LIS
connectivity, fictitious patient data were returned by the
MuxBCT server. The data were visible by the participant within
the app during the study, which helped to ensure a high degree
of realism. If the system had been connected to the LIS, it may
have induced some additional delays during use of the app while
data was being transferred. However, any such delays would
only affect test setup and result reporting and would not have
changed the evaluation of how the MuxBCT app aided in the
analysis and interpretation of test results, as these steps of the
MuxBCT app do not require communication with the LIS.
Data security of patient information is an important factor to
consider in the development of apps for mobile phones and
tablets [18,19]. To secure the privacy of patient information,
several security related features were built into the MuxBCT
app. The design of security features for the MuxBCT app has
a high similarity to those described by Landman et al used in
the implementation of the CliniCam mobile phone app [19].
While the MuxBCT app required access to the hospital’s
protected Wi-Fi network for use, the participants did not
experience any loss of connectivity during the study. As clinical
laboratories are of fixed dimensions, it should be a manageable
task to setup adequate Wi-Fi coverage throughout an entire
laboratory. Other mobile device apps for facilitation of clinical
workflow may experience challenges with sufficient Wi-Fi
network coverage, as larger areas need to be covered [18,19].
Future development on the MuxBCT app could include the
functionality to directly communicate test results electronically
to selective stakeholders, for example, the patient’s treating
physician or to clinical microbiologists within the DCM. This
could potentially reduce errors related to communication of test
results and reduce the total test turnaround time [20,21]. Future
evaluation studies will be required to see how the MuxBCT app
affects the use of the MuxBCT diagnostic test once both are put
into daily use in a clinical microbiology laboratory. It should
be stressed that the current iteration of the MuxBCT app was
developed as a research project. If future development of the
MuxBCT app aims to prepare it for commercialization and
regular use in a clinical microbiology laboratory, the app must
conform to national regulatory requirements governing medical
devices.
Limitations
A significant limitation of this study is the low number of study
participants. Each participant, who was an expert in the field of
use for the MuxBCT app, conducted an analysis of a positive
blood culture sample with two microorganisms. This allowed
for a total of 8 microorganisms being successfully identified.
While this number is too low to accurately determine the quality
of MuxBCT diagnostic test results being facilitated by the
MuxBCT app, these results in combination with the results from
observations and debriefing interviews provided an insight into
the usability of the MuxBCT app.
The realism of the study was also diminished to some degree
by the MuxBCT diagnostic test being unavailable for the study.
The test was substituted with the QuickFISH tests, and as there
is a high coherence between the QuickFISH tests and the
MuxBCT, it is unlikely that this had a significant impact on the
study results.
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The results of the clinical simulation cannot be generalized, as
they are specific to the MuxBCT app being evaluated. However,
our study results indicate that a clinical simulation is a valuable
tool for evaluating the usability of a mobile device app that aim
to support clinical workflow. Other developers and implementers
may find this as an effective tool to use preimplementation. The
system design of the MuxBCT app and the considerations of
security features may inspire the design choices of other mobile
apps being developed for clinical use. However, their effect
should be evaluated through a full system implementation in
daily clinical workflow.
Related Work
To our knowledge, there has not been any previous publication
describing the use of a mobile phone or tablet computer app for
facilitating the use of a diagnostic test in a clinical laboratory.
However, the use of mobile phone or tablet computer apps
designed for use by health care professionals in clinical settings
is becoming increasingly common [7,8,18,19,22].
There is a growing interest in clinical simulation studies as a
tool for evaluating usability of hospital information technology
(HIT) [23,24]. It is a common goal of simulation studies to
create a near-live simulation, which requires a setting
representative to where the system will be used [1,23,25,26].
While most clinical simulation studies focus on the evaluation
of stationary HIT, some simulation studies have been used to
examine the usability of HIT designed for use on mobile devices
[27,28]. This study differentiates itself from previous clinical
simulation studies, as it took place in a clinical laboratory. This
meant that the context of use for the system being evaluated did
not involve patient contact, but involved a focus on the
diagnostic test laboratory analysis process, which included a
focus on the use of laboratory equipment as part of the user
workflow. A realistic simulation of the use of specialized
laboratory equipment may be difficult to achieve outside an
actual clinical laboratory.
Conclusions
The MuxBCT tablet computer app facilitates the workflow of
a novel molecular diagnostic test using PNA FISH technology
for blood culture analysis and was developed with system
flexibility and security of patient data as high priorities. The
app was developed based on previous analysis of user
requirements. However, additional functionalities such as user
authentication and user inactivity detection were added to create
a secure app. The security features are vital to protect patient
data. A preliminary usability evaluation was conducted as a
clinical simulation study in a clinical microbiology laboratory.
The study aimed to provide a high degree of realism by having
end users conduct fluorescence microscopy of molecular
diagnostic tests employing available PNA FISH technology,
while using the MuxBCT app to facilitate the workflow. The
study results indicate that users can successfully use the app to
facilitate the MuxBCT diagnostic test workflow. All diagnostic
test results were interpreted, entered, and communicated
successfully to the MuxBCT server with use of the MuxBCT
tablet app, which validates the system design considerations.
The study provided useful feedback on the app usability, for
example, in regards to font size and tablet size. The clinical
simulation method can be a valuable tool for evaluating the
usability of mobile apps intended for clinical use, as the method
provides insights into complex use case scenarios where context
of use is important.
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